Company record
Chengdu Innovation Pharmaceutical Co., Ltd.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Chengdu Innovation Pharmaceutical Co., Ltd..
Warning letters
-
DrugsChengdu Innovation Pharmaceutical Co., Ltd.
FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.
High risk